Breast Cancer News

Community oncologists who received peer coaching from cancer genetics experts more frequently ordered genetic testing for their patients, according to study results.

The addition of ribociclib to adjuvant endocrine therapy significantly reduced the risk for disease recurrence among patients with hormone receptor-positive, HER2-negative early breast cancer, according to the agent’s manufacturer.

Compared with other people with breast cancer, those with a preexisting severe mental illness were less likely to receive appropriate treatment and more likely to experience delays in receiving treatment, findings in Psycho-Oncology showed.

A review of established associations between cancer waiting times and treatment outcomes has identified discrepancies in the measurement and reporting of lag times between diagnosis and treatment.

In this episode, host Shikha Jain, MD, speaks with Isabelle Choi, MD, about the use of proton therapy in radiation oncology, improving accessibility to radiation technology and more.

Low household income appeared independently associated with higher 21-gene recurrence scores and significantly worse survival outcomes among women with ER-positive breast cancer, according to data published in JAMA Network Open.

Current or recent use of progestogen-only contraceptives was associated with a “slight” increase in breast cancer risk, according to findings from a nested case-control study and meta-analysis published in PLOS Medicine.

The concept of cancer vaccination has generated excitement in the scientific community for decades.

Major discrimination events appeared associated with increased frailty among Black survivors of various cancer types, according to study results published in Cancer.

Edith P. Mitchell, MD, MACP, FCCP, FRCP (London), has been named enterprise vice president for cancer disparities at Jefferson Health’s Sidney Kimmel Cancer Center.